Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).
about
Modern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationImpacts of Ionizing Radiation on the Different Compartments of the Tumor MicroenvironmentEffects of Charged Particles on Human Tumor CellsRadiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgeryThe tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?The biology of radiosurgery and its clinical applications for brain tumors.Radiobiology of radiosurgery for the central nervous systemEpigenetics meets radiation biology as a new approach in cancer treatmentRadiotherapy and the tumor stroma: the importance of dose and fractionationThe abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevantGastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation TherapyImmunological effect of local ablation combined with immunotherapy on solid malignancies.Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization.Role of HIF-1α in response of tumors to a combination of hyperthermia and radiation in vivo.Retrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs)The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy.The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.New challenges in high-energy particle radiobiology.Tumor physiological changes during hypofractionated stereotactic body radiation therapy assessed using multi-parametric magnetic resonance imaging.Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma modelVasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Erythrocyte stiffness during morphological remodeling induced by carbon ion radiationImproved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer.CT perfusion imaging as an early biomarker of differential response to stereotactic radiosurgery in C6 rat gliomas.Optical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma.Microbeam radiation therapy alters vascular architecture and tumor oxygenation and is enhanced by a galectin-1 targeted anti-angiogenic peptideRadio-sensitivities and angiogenic signaling pathways of irradiated normal endothelial cells derived from diverse human organs.Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy.A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?Low Z target switching to increase tumor endothelial cell dose enhancement during gold nanoparticle-aided radiation therapy.Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plansOutcomes and toxicity of radiotherapy for refractory bone and soft tissue sarcomas.Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.Exploring two two-edged swords.A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and RadiotherapyXIAP-associating factor 1, a transcriptional target of BRD7, contributes to endothelial cell senescence.Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era
P2860
Q26744490-44435914-1BF9-431E-B3C7-64F1120096C4Q26750420-65BD1C72-D037-4CF3-9BBB-06D74D0494E4Q26767252-27D13B50-5C45-459D-A450-1A577503392BQ26772259-0D6ED975-CB56-481C-8173-728500037D46Q26823489-8C3164F0-6ABD-4F72-90F5-562487FF78BAQ26829154-C20CF17C-5DDC-42D1-8679-724992E79216Q27011342-5B766641-A4D2-4B5B-BBBA-CBCD19D1D431Q27014984-8F6B80AF-5B0D-449D-89FE-F567A9D581A6Q27022685-86073462-1FE1-4947-969D-1226B6467FA4Q28081732-A3615BE2-A9F1-4F36-9091-900863AE408FQ28086904-063D835F-273F-4267-BD67-E6086D6EA8BBQ30354580-66288FB6-17AA-459B-B591-3DC663B52671Q30366774-DC937C14-E3BE-48EC-881E-B0DC503F9B72Q32174462-BEEB7C5F-8F4D-4350-84E0-7FA20270A9C6Q33571109-290CDB63-998E-420E-AA7E-17D999060F15Q33618834-DB5252D8-DB76-43E0-A358-291E0E5EFD08Q33705268-8C51ACEA-F846-4B9F-83AD-F74160BA7D7AQ33782346-390CC299-376B-4713-A254-77E75F5851D9Q33913989-3740EDBD-2B28-4AA1-8B47-A03F9E184C7AQ33930599-34B8FB39-7D0D-4AC5-8BC4-E0A0E9DB97A8Q34157162-7D82FD4E-39E7-4FC9-A2E0-E07F7BE700A4Q34404209-C9651424-20AE-46FD-86FD-0A1CB1A1D68BQ34524784-ECD20FC0-8EC1-4A66-8B57-D554A5EBE79FQ35082792-D220FCD2-B230-48D6-8ABB-52D696463A28Q35348742-E713DC97-F936-45D1-9A1A-DD88D3367C83Q35903928-9FC4508D-8207-419F-A0F9-38131C3819DEQ36082119-3E751190-F24B-4654-B233-052B51D4E038Q36086207-C226AE1E-6A9C-426B-A390-0916C39156B4Q36105408-F25CECCC-AB2E-4DC5-A645-80E0C98F51C2Q36286199-635791F2-C9C1-4AC1-9791-2FD8DDBAE5E6Q36421581-39018C09-669B-436E-B9DD-2E6BD6ADF407Q36493592-68653DA6-2BC9-4EA5-9CE7-608545A4877FQ36502380-A1F25803-33CA-4F09-83DA-5570AB5A7BEEQ36509821-05DC1339-6C63-4F2D-B621-71CEF85AB10FQ36611916-AE804D91-1067-4B01-B09D-36C271A09472Q36651935-4F04EA4B-C9A5-404C-8129-DE9A927FFF03Q36902053-CF246A8F-ADA2-45F8-AC23-8E29FE5B8EFFQ36905617-34551D97-14D7-43A4-99A9-877785FCFA92Q37068894-CDF77D3B-477A-4D4B-89A9-A32E212FC6A3Q37118895-CDC41A9A-074C-42DC-8E10-F3054D8D80CE
P2860
Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Radiation-induced vascular dam ...... d radiotherapy (SBRT and SRS).
@en
Radiation-induced vascular dam ...... hypofractionated radiotherapy
@nl
type
label
Radiation-induced vascular dam ...... d radiotherapy (SBRT and SRS).
@en
Radiation-induced vascular dam ...... hypofractionated radiotherapy
@nl
prefLabel
Radiation-induced vascular dam ...... d radiotherapy (SBRT and SRS).
@en
Radiation-induced vascular dam ...... hypofractionated radiotherapy
@nl
P2093
P356
P1433
P1476
Radiation-induced vascular dam ...... d radiotherapy (SBRT and SRS).
@en
P2093
Chang W Song
Heon Joo Park
Robert J Griffin
Seymour H Levitt
Susanta Hui
P304
P356
10.1667/RR2773.1
P577
2012-01-09T00:00:00Z